Diabetes
Conference Coverage
ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk
Another major change in the new ESC guideline revision is introduction of a CVD risk calculator intended to estimate the risk among people with...
From the Journals
Liraglutide fixes learning limit tied to insulin resistance
The normalization in associative learning that one dose of liraglutide produced in people with obesity “fits with studies showing that these drugs...
From the Journals
Apple cider vinegar, fenugreek best herbal remedies for T2D: Review
“You need to look at the evidence for each individual remedy; it’s not just about what plant it is, but it’s about what preparation, what dose....
Latest News
Continuous glucose monitors for pregnant patients?
The benefits of these technologies for patients with gestational diabetes are unclear in consideration of the...
Commentary
Human frailty is a cash cow
Humans are frail and easily taken advantage of by the brilliant and highly motivated strategic planning and execution of Big Agriculture, Big Food...
News from the FDA/CDC
FDA approves new tubeless insulin pump
It offers users a choice of bolusing directly from the pump or from a handheld remote-control device.
Latest News
Type 1 diabetes management improves as technology advances
Automated insulin delivery systems have reduced A1c levels, but many still are not achieving numbers under 7%.
From the Journals
Artificial sweeteners no help for weight loss: Review
An updated review of the leading scientific evidence on artificial sweeteners suggests that far from positively affecting our health, they have “...
From the Journals
Dementia diagnosis a good time to reduce polypharmacy
Time of diagnosis can be a potential inflexion point for deprescribing long-term medications with safety risks, limited benefit, or possible...
From the Journals
Simple blood test may predict heart and kidney risk in T2D
“Three out of the four biomarkers are already clinically and commercially available,” while the fourth, for insulin-like growth factor binding...
From the Journals
Lower is better for blood glucose to reduce heart disease
“We uncovered compelling evidence that for blood sugar levels within the ‘normal’ range, it was a case of ‘the lower the better’ in protecting...